Detalles de la búsqueda
1.
Tumour-agnostic plasma assay for circulating tumour DNA predicts outcome in recurrent and/or metastatic squamous cell carcinoma of the head and neck treated with a PD-1 inhibitor.
Eur J Cancer
; 195: 113372, 2023 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37913682
2.
Paclitaxel plus carboplatin and durvalumab with or without oleclumab for women with previously untreated locally advanced or metastatic triple-negative breast cancer: the randomized SYNERGY phase I/II trial.
Nat Commun
; 14(1): 7018, 2023 11 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-37919269
3.
Author Correction: Paclitaxel plus carboplatin and durvalumab with or without oleclumab for women with previously untreated locally advanced or metastatic triple-negative breast cancer: the randomized SYNERGY phase I/II trial.
Nat Commun
; 14(1): 8223, 2023 Dec 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-38086864
Resultados
1 -
3
de 3
1
Próxima >
>>